Anuh Pharma Ltd.
NSE: ANUHPHR | BSE: 506260
₹84.42
As on 28-Aug-2026 10:19IST
Market cap
₹838 Cr
Revenue (TTM)
₹779 Cr
P/E Ratio
19
P/B Ratio
2.3
Div. Yield
1.8 %
Quality Score
4/10
Growth Score
5/10
Valuation Score
7/10
Momentum Score
5/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹44 Cr
-
ROE
12.1 %
-
ROCE
16 %
-
Industry P/E
54.32
-
EV/EBITDA
11.6
-
Debt to Equity
0
-
Book Value
₹36.3
-
EPS
₹4.4
-
Face value
5
-
Shares outstanding
100,224,000
10 Years Aggregate
CFO
₹195.07 Cr
EBITDA
₹433.31 Cr
Net Profit
₹317.87 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Anuh Pharma
| 4.8 | 4.6 | 10.1 | -3.4 | -- | -- | -- |
|
BSE Healthcare
| 18.4 | 2.4 | 8.3 | 16.6 | 23.0 | 14.7 | 12.3 |
|
Company
|
2025
|
|---|---|
|
Anuh Pharma
| -30.3 |
|
BSE Small Cap
| -6.6 |
|
BSE Healthcare
| -3.3 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Anuh Pharma
|
84.4 | 837.6 | 779.0 | 44.2 | 6.9 | 13 | 19 | 2.3 |
| 1,349.6 | 16,668.7 | 2,590.4 | 603.0 | 29.3 | 19.6 | 27.6 | 4.8 | |
| 587.1 | 11,096.3 | 885.7 | 234.9 | 27.8 | 18 | 47.2 | 5.0 | |
| 1,489.3 | 15,505.2 | 1,108.4 | 270.2 | 28.3 | 14.5 | 56.3 | 7.5 | |
| 1,869.2 | 35,650.2 | 9,683.5 | 1,019.0 | 15.7 | 21.3 | 35.2 | 6.8 | |
| 23,550.0 | 30,141.1 | 2,371.8 | 497.8 | 28.0 | 28.5 | 60.6 | 14.9 | |
| 951.2 | 5,564.5 | 942.6 | 9.9 | 0.3 | 1.2 | 642.1 | 4.3 | |
| 1,478.5 | 6,781.4 | 691.7 | 130.8 | 24.5 | 14.5 | 53.7 | 7.0 | |
| 1,125.3 | 12,784.7 | 675.6 | 183.6 | 32.2 | 22.7 | 70 | 13.8 | |
| 364.7 | 10,389.8 | 8.8 | -352.4 | -4,228.0 | -80.8 | -- | 18.7 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsStock Rating update, April 08, 2024
1 min read•By Value Research
About Anuh Pharma
Anuh Pharma Limited engages in the manufacture and sale of bulk drugs and chemicals in India. It offers active pharmaceutical ingredients, including macrolides, anti-TB, anti-bacterial, anti-asthmatics, anti-diabetics, intermediates, expectorant,... quinolones, anti-malarial, anti-gout, anti-biotic, anti-platelet, and antihistamines; and corticosteroids, including anti-inflammatory, immunosuppressant, anti-pruritic, anti-mitotic. The company also develops products, such as coagulants, gastrointestinal, anti convulsants, and cholesterol drugs. It also exports its products. The company was incorporated in 1960 and is headquartered in Mumbai, India. Read more
-
Incorporated
1960
-
Chairman
Arun L Todarwal
-
Managing Director
--
-
Headquarters
Mumbai, Maharashtra
-
Website
FAQs for Anuh Pharma
What is the current share price of Anuh Pharma Ltd Today?
The share price of Anuh Pharma Ltd is ₹84.42 (NSE) and ₹83.97 (BSE) as of 28-Aug-2026 10:19 IST. Anuh Pharma Ltd has given a return of -3.4% in the last 1 years.
What is the current PB & PE ratio of Anuh Pharma Ltd?
The P/E ratio of Anuh Pharma Ltd is 18.96 times as on 27-Aug-2026, a 65 discount to its peers’ median range of 54.32 times.
The P/B ratio of Anuh Pharma Ltd is 2.30 times as on 27-Aug-2026, a 46 discount to its peers’ median range of 4.28 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2026 |
16.39 |
1.91 |
2025 |
7.88 |
2.29 |
2024 |
10.25 |
4.23 |
2023 |
11.03 |
1.65 |
2022 |
14.09 |
2.01 |
What is the 52 Week High and Low of Anuh Pharma Ltd?
The 52-week high and low of Anuh Pharma Ltd are Rs 93.00 and Rs 67.00 as of 28-Aug-2026.
What is the market cap of Anuh Pharma Ltd?
Anuh Pharma Ltd has a market capitalisation of ₹ 838 Cr as on 27-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Anuh Pharma Ltd?
Before investing in Anuh Pharma Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
